China Life Posts Record Revenue, Eyes AI and Chip Investments
SCMP · 1 SOURCES1 day ago2 MIN
Summary
China Life Insurance, the country's largest life insurer, has delivered record-breaking first-half results for 2024, with revenue reaching 434.3 billion yuan (US$64.6 billion), representing an 81.5 percent year-on-year surge . Net profit soared more than 228 percent to 134.5 billion yuan, driven by business development with risk control, product diversification, refined asset allocation and robust investment returns . The Shanghai- and Hong Kong-listed company announced it will significantly increase investments in technology sectors including artificial intelligence, semiconductors, healthcare, biotechnology and new-generation infrastructure .
Key Points
- Revenue reached 434.3 billion yuan (US$64.6 billion), up 81.5 percent year on year in first half of 2024
- Net profit surged over 228 percent to 134.5 billion yuan, according to interim results released on Thursday
- Vice-president Liu Hui said investments in new quality productive forces represent a key growth driver for differentiated returns
- Technology finance investments exceeded 1 trillion yuan during the half-year period, with new productive forces investments surpassing 540 billion yuan
- Premiums from new policies increased 11.6 percent to 180 billion yuan year on year
- Board proposed interim cash dividend of 3.58 yuan per 10 shares, totalling 10.12 billion yuan, up 50.4 percent year on year
- Investment portfolio includes ChangXin Memory Technologies, with plans to expand into AI, chips and biotech
Why It Matters
China Life's aggressive pivot toward technology investments signals a broader shift among China's traditional financial institutions to back strategic sectors amid Beijing's drive for technological self-sufficiency . The insurer's move could reshape competitive dynamics in both the financial and technology investment landscapes, with implications for Hong Kong-listed insurance stocks and mainland capital flows into AI and semiconductor firms .
China Life's aggressive pivot toward technology investments signals a broader shift among China's traditional financial institutions to back strategic sectors amid Beijing's drive for technological self-sufficiency . The insurer's move could reshape competitive dynamics in both the financial and technology investment landscapes, with implications for Hong Kong-listed insurance stocks and mainland capital flows into AI and semiconductor firms .